Caring for the Medically Ill: Improvements in the Management of Thromboembolic Disease
Highlights from the 2002 Annual Session of the American College of Physicians - American Society of Internal Medicine (ACP-ASIM)
Activity Date: August 2002  — Activity Info: Volume 2, (12)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity



    Bruce Perler, MD
    Department of Surgery
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Perler reports having no financial relationships with corporate organizations.

    Charles Locke, MD
    Assistant Professor
    Department of Internal Medicine
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Locke reports receiving honoraria from Aventis.


    Marc Cohen, MD, FACP
    Professor of Medicine
    Division of Cardiology
    MCP Hahnemann University School of Medicine
    Philadelphia, Pennsylvania
    • Dr Cohen reports receiving grant/research support from Aventis, Merck, Guidant, and COR; and serving as a consultant for DATAscope, Aventis and AstraZeneca.

    Russell D. Hull, MBBS, MSc, FRCPC, FACP, FCCP, FRACP
    Professor of Medicine
    Director, Thrombosis Research Unit
    University of Calgary
    Foothills Hospital
    Alberta, Canada
    • Dr Hull reports receiving grant/research support from, and serving as a consultant for Aventis, Pharmacia, DuPont, Emisphere and LEO Pharma.

    Geno J. Merli, MD, FACP
    Ludwig A. Kind Professor
    Director, Division of Internal Medicine
    Department of Medicine
    Jefferson Medical College
    Thomas Jefferson University
    Philadelphia, Pennsylvania
    • Dr Merli reports receiving grant/research support and honoraria from AstraZeneca and Aventis.

    Victor F. Tapson, MD, FACP
    Associate Professor of Medicine
    Division of Pulmonary and Critical Care Medicine
    Duke University Medical Center
    Durham, North Carolina
    • Dr Tapson reports serving as a consultant for Aventis.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

Off Label Product Discussion
Faculty have disclosed that their articles have referenced the following unlabeled/unapproved uses of drugs and/or products: Enoxaparin (lovanox).

Home | Contact Us | View Account | Need Help?